Addiction is yet another area where GLP-1s might be effective. Preliminary evidence looks promising, but questions remain.
Some of what RFK Jr. says about obesity prevention isn't new. But after having coined the catchy MAHA acronym, it’s likely ...
The latest Health Survey for England shows that 64% of adults were overweight or obese in 2022. However, Dr Kath McCullough, ...
Obese people ‘will have to wait’ for Mounjaro amid carefully managed NHS rollout - The decision will help ‘protect other ...
Amid the war on obesity, a clear winner has emerged in a battle between two weight-loss injectables. Zepbound (tirzepatide), ...
Berberine, green tea extract and taurine are just some of the ingredients advertised as being able to ‘boost’ GLP-1 levels.
NHS patients waiting for an obesity drug may be given a blow as its revealed that fewer than 10 per cent of those eligible ...
After this, the situation will be reviewed by Nice, who will provide further guidance on the rollout. Mounjaro is a ...
Mounjaro is the brand name for a drug called tirzepatide, which is a glucagon-like peptide-1 (GLP-1) that helps to lower ...
In a new guidance statement, the American Diabetes Association advises against the use of unapproved products, warning of ...
Patients lost an average of 20.2% of their weight with tirzepatide over 72 weeks versus 13.7% with semaglutide.